Cancer News and Research

Latest Cancer News and Research

DARA BioSciences provides additional details of DB959 Phase I study for Type 2 Diabetes

DARA BioSciences, provided additional details from the recently completed Phase I clinical study for DB959, its PPAR delta/gamma agonist, an oral drug in development for the treatment of Type 2 Diabetes.

6 Jan 2011

University of Michigan lab takes top honours in worldwide protein prediction competition

The University of Michigan Health System took top honors in the Critical Assessment of Techniques for Protein Structure Prediction, a biennial scientific competition to test protein structure and function prediction methods developed by laboratories all over the world.

5 Jan 2011

First Edition: January 5, 2011

In today's headlines, reports about how Republicans and Democrats are preparing for the new power dynamic in the House.

5 Jan 2011

IRIS ships 3,000th iQ200 Automated Urine Microscopy Analyzer to Sarasota Memorial Hospital

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, has shipped its 3,000th iQ200Automated Urine Microscopy Analyzer.

5 Jan 2011

SuperGen initiates enrollment in first human trial of SGI-110 in MDS and AML

SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).

5 Jan 2011

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

The American Heart Association is participating in an international effort to prepare for a United Nations (UN) high-level summit next year on non-communicable diseases (NCDs). These diseases — mainly cardiovascular illnesses including stroke, diabetes, cancer and chronic respiratory conditions — were estimated to cause more than 60 percent of deaths worldwide in 2005.

5 Jan 2011

New laboratory manual on imaging in developmental biology

Imaging technologies have revolutionized the study of developmental biology and are now essential tools for researchers in the field. A newly released laboratory manual, Imaging in Developmental Biology, presents a comprehensive set of visualization methods specifically for developmental biologists. It is the newest volume in a series of imaging manuals published by Cold Spring Harbor Laboratory Press.

5 Jan 2011

Study shows adolescents who were breastfed at birth have stronger leg muscles

Breast feeding new born babies has lots of advantages in the short and in the long-term for babies. A study has confirmed the recently discovered benefits, which had not been researched until now. Adolescents who are breast fed at birth have stronger leg muscles than those who received artificial milk.

5 Jan 2011

ImmunGene, Cephalon Australia collaborate to advance new class of protein therapeutics

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.

5 Jan 2011

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.

5 Jan 2011

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

Star Scientific Inc.'s plan to submit a new, moist-snuff product for evaluation by the Food and Drug Administration as a "modified risk" tobacco product shows the vital importance of the new law giving the FDA the authority to regulate tobacco products and any health claims used to market them.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Men are more willing to receive HPV vaccine, trend may help reduce cancer deaths

Men are more willing to receive human papillomavirus vaccine when they learn the vaccine can prevent cancer, according to a recent University of North Carolina at Chapel Hill study.

5 Jan 2011

Canadian Cancer Society launches sixth annual Driven to Quit Challenge

Results of an Angus Reid Public Opinion survey conducted in December show that 20 per cent of Ontario adults are current tobacco users, including cigarettes, cigars and chew tobacco, and that half of them have tried unsuccessfully to quit in the past.

5 Jan 2011

Study identifies sailing injuries

Just as the site for the 2013 America's Cup has been announced, a study from Rhode Island Hospital highlights that the sport isn't always smooth sailing. The study was published recently in the journal Wilderness and Environmental Medicine.

5 Jan 2011

Safe vaccine protects mice against effects of cocaine

Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine.

5 Jan 2011

Anti-tobacco laws can reduce smoking habits in Europe

The Global Alliance for Chronic Diseases has announced its intention to release a Request for Applications on Implementation Research on Hypertension in Low and Middle Income Countries.

5 Jan 2011

Elis granted exclusive rights to market Apricus Bio's Vitaros in the Gulf and part of the Middle East

Apricus Biosciences, Inc. and Elis Pharmaceuticals, announced today that the two companies have entered into a licensing agreement granting Elis the exclusive rights to market Apricus Bio's new drug for erectile dysfunction, Vitaros®, in the Gulf and part of the Middle East. "This new agreement is the next step in our strategy of seeking to partner Vitaros in more than 100 countries around the world," said Dr. Bassam Damaj, President and Chief Executive Officer of Apricus Bio.

5 Jan 2011

Alnylam presents ALN-VSP Phase I trial results for liver cancer

Alnylam Pharmaceuticals, a leading RNAi therapeutics company, today presented new clinical data from its ALN-VSP Phase I liver cancer trial in a presentation at the Dana-Farber Cancer Institute in Boston. Results from molecular analysis of human biopsy samples showed achievement of pharmacologically relevant siRNA drug levels in tissues.

5 Jan 2011

Low-radiocarbon nutrition permanently reduces genetic damage to brain cells

A new method of child and maternal nutrition could prevent a specific type of genetic damage that would otherwise occur in up to 160 million brain cells in each person over their lifetime. Preventing this genetic damage could have significant implications related to aging and cancer.

5 Jan 2011

Cancer News and Research

Latest Cancer News and Research

DARA BioSciences provides additional details of DB959 Phase I study for Type 2 Diabetes

University of Michigan lab takes top honours in worldwide protein prediction competition

First Edition: January 5, 2011

IRIS ships 3,000th iQ200 Automated Urine Microscopy Analyzer to Sarasota Memorial Hospital

SuperGen initiates enrollment in first human trial of SGI-110 in MDS and AML

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

New laboratory manual on imaging in developmental biology

Study shows adolescents who were breastfed at birth have stronger leg muscles

ImmunGene, Cephalon Australia collaborate to advance new class of protein therapeutics

EUSA receives FDA Priority Review status for ERWINAZE BLA

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Men are more willing to receive HPV vaccine, trend may help reduce cancer deaths

Canadian Cancer Society launches sixth annual Driven to Quit Challenge

Study identifies sailing injuries

Safe vaccine protects mice against effects of cocaine

Anti-tobacco laws can reduce smoking habits in Europe

Elis granted exclusive rights to market Apricus Bio's Vitaros in the Gulf and part of the Middle East

Alnylam presents ALN-VSP Phase I trial results for liver cancer

Low-radiocarbon nutrition permanently reduces genetic damage to brain cells

Industry Focus: Cell & Gene Therapy eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in